NO20022867L - Syklopentenonderivater - Google Patents

Syklopentenonderivater

Info

Publication number: NO20022867L
Authority: NO; Norway
Prior art keywords: syklopentenonderivater
Prior art date: 1999-12-16

Application number

NO20022867A

Other languages

English (en)

Other versions

NO20022867D0 (no

Inventor

Stanley Michael Roberts

Maria Gabriella Santoro

Eric Emil Aenggaard

Original Assignee

Charterhouse Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-16

Filing date

2002-06-14

Publication date

2002-08-12

2002-06-14 Application filed by Charterhouse Therapeutics Ltd filed Critical Charterhouse Therapeutics Ltd

2002-06-14 Publication of NO20022867D0 publication Critical patent/NO20022867D0/no

2002-08-12 Publication of NO20022867L publication Critical patent/NO20022867L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
- C07C69/40—Succinic acid esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/80—Phthalic acid esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Cardiology (AREA)
Toxicology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)

NO20022867A 1999-12-16 2002-06-14 Syklopentenonderivater NO20022867L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9929702.0A GB9929702D0 (en)	1999-12-16	1999-12-16	Chemical compounds and their uses
PCT/GB2000/004868 WO2001044254A1 (en)	1999-12-16	2000-12-18	Cyclopenteneone derivatives

Publications (2)

Publication Number	Publication Date
NO20022867D0 NO20022867D0 (no)	2002-06-14
NO20022867L true NO20022867L (no)	2002-08-12

Family

ID=10866408

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022867A NO20022867L (no)	1999-12-16	2002-06-14	Syklopentenonderivater

Country Status (13)

Country	Link
US (1)	US20030186941A1 (no)
EP (1)	EP1240171A1 (no)
JP (1)	JP2003516995A (no)
KR (1)	KR20020062349A (no)
CN (1)	CN1409715A (no)
AU (1)	AU2202401A (no)
CA (1)	CA2393972A1 (no)
GB (1)	GB9929702D0 (no)
HK (1)	HK1048638A1 (no)
IL (1)	IL150132A0 (no)
NO (1)	NO20022867L (no)
WO (1)	WO2001044254A1 (no)
ZA (1)	ZA200204458B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003051893A2 (en) *	2001-12-14	2003-06-26	Charterhouse Therapeutics Limited	Improvements in pharmaceutical compositions
EP1456163A2 (en) *	2001-12-14	2004-09-15	Charterhouse Therapeutics Limited	Improvements in pharmaceutical compositions
GB0218261D0 (en) *	2002-08-06	2002-09-11	Charterhouse Therapeutics Ltd	Improvements in pharmaceutically useful compounds
GB0218260D0 (en) *	2002-08-06	2002-09-11	Charterhouse Therapeutics Ltd	Improvements in pharmaceutically useful compounds
AU2013208308B2 (en)	2012-01-09	2017-03-02	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods of treating or preventing insulin resistance and associated diseases and conditions
EP2919776B1 (en)	2012-11-15	2017-02-01	The U.S.A. as represented by the Secretary, Department of Health and Human Services	Methods of treating patients infected with hiv and htlv
EP3049072A4 (en) *	2013-09-25	2017-10-04	William Marsh Rice University	Synthesis of delta 12-pgj3 and related compounds
CN106518643B (zh) *	2016-10-14	2019-02-15	宁波大学	一种环戊烯酮类化合物及其制备方法和用途
CN106966886B (zh) *	2017-01-24	2020-06-16	宁波大学	一种环戊烯酮类化合物及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4954519A (en) *	1987-04-28	1990-09-04	Georgia Tech Research Corporation	Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
DE3586085D1 (de) *	1984-10-22	1992-06-25	Teijin Ltd	Antitumor-4-hydroxy-2-zyklopentenonen.
JPS61205230A (ja) *	1985-03-09	1986-09-11	Nippon Iyakuhin Kogyo Kk	アルキリデンシクロペンテノン誘導体及びその製法
JPS6244A (ja) *	1985-06-25	1987-01-06	Nippon Iyakuhin Kogyo Kk	２−ハロ−２−シクロペンテノン誘導体及びその製法
JPS62114933A (ja) *	1985-11-13	1987-05-26	Nippon Iyakuhin Kogyo Kk	２−ハロ−２−シクロペンテノン誘導体及びその製法
JPS62129245A (ja) *	1985-11-30	1987-06-11	Nippon Iyakuhin Kogyo Kk	２−ハロ−２−シクロペンテノン誘導体及びその製法
US6410516B1 (en) *	1986-01-09	2002-06-25	President & Fellows Of Harvard College	Nuclear factors associated with transcriptional regulation
US5216183A (en) *	1988-04-19	1993-06-01	Teijin Limited	Cyclopentanone/cyclopentenone derivative
AU615534B2 (en) *	1988-04-19	1991-10-03	Teijin Limited	2-substituted-2-cyclopentenones
US5338844A (en) *	1989-10-19	1994-08-16	Teijin Limited	2-substituted-2-cyclopentenone compound and anticancer agent and bone formation accelerator comprising same as active ingredient
EP0659728A4 (en) *	1992-09-10	1997-08-06	Teijin Ltd	4-HYDROXY-2-CYCLOPENTENONE DERIVATIVES AND CARCINOSTATICS AND OSTEOGENESIS PROMOTERS CONTAINING THEM.
GB9418762D0 (en) *	1994-09-16	1994-11-02	Bayer Ag	Use of substituted cyclopentane-DI-and-triones
IT1289250B1 (it) *	1996-12-13	1998-09-29	Consiglio Nazionale Ricerche	Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb
IT1284853B1 (it) *	1996-06-18	1998-05-22	Consiglio Nazionale Ricerche	Impiego del 2-ciclopenten-1-one come induttore di hsp70.
JP3790273B2 (ja) *	1996-09-27	2006-06-28	タカラバイオ株式会社	シクロペンテノン類、その製造方法及び用途
CN100391940C (zh) *	1997-03-05	2008-06-04	宝生物工程株式会社	化合物
CN1156432C (zh) *	1997-03-11	2004-07-07	宝酒造株式会社	环戊烯酮衍生物
ATE274904T1 (de) *	1997-03-28	2004-09-15	Takara Bio Inc	4,5-dihydroxy-2-cyclopenten-1-on für die behandlung von diabetes mellitus
US6284801B1 (en) *	1997-04-01	2001-09-04	Takara Shuzo Co., Ltd.	Antirheumatic agents
DE69820267T2 (de) *	1997-06-30	2004-09-16	Takara Bio Inc., Otsu	Cyclopentenonderivate

1999
- 1999-12-16 GB GBGB9929702.0A patent/GB9929702D0/en not_active Ceased
2000
- 2000-12-18 CA CA002393972A patent/CA2393972A1/en not_active Abandoned
- 2000-12-18 EP EP00985616A patent/EP1240171A1/en not_active Withdrawn
- 2000-12-18 KR KR1020027007791A patent/KR20020062349A/ko not_active Withdrawn
- 2000-12-18 JP JP2001544744A patent/JP2003516995A/ja not_active Withdrawn
- 2000-12-18 WO PCT/GB2000/004868 patent/WO2001044254A1/en not_active Ceased
- 2000-12-18 IL IL15013200A patent/IL150132A0/xx unknown
- 2000-12-18 US US10/168,036 patent/US20030186941A1/en not_active Abandoned
- 2000-12-18 AU AU22024/01A patent/AU2202401A/en not_active Abandoned
- 2000-12-18 HK HK02108074.0A patent/HK1048638A1/zh unknown
- 2000-12-18 CN CN00817160A patent/CN1409715A/zh active Pending
2002
- 2002-06-04 ZA ZA200204458A patent/ZA200204458B/en unknown
- 2002-06-14 NO NO20022867A patent/NO20022867L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL150132A0 (en)	2002-12-01
WO2001044254A1 (en)	2001-06-21
HK1048638A1 (zh)	2003-04-11
US20030186941A1 (en)	2003-10-02
NO20022867D0 (no)	2002-06-14
CA2393972A1 (en)	2001-06-21
JP2003516995A (ja)	2003-05-20
KR20020062349A (ko)	2002-07-25
GB9929702D0 (en)	2000-02-09
EP1240171A1 (en)	2002-09-18
ZA200204458B (en)	2003-04-17
AU2202401A (en)	2001-06-25
CN1409715A (zh)	2003-04-09

Publication	Publication Date	Title
DE50010505D1 (de)	2005-07-14	Gurtaufrollersystem
DE122007000064I2 (de)	2010-03-25	Erythropoietinkonjugate
DE19983871T1 (de)	2002-01-31	Fönvorrichtung
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
DE60001240D1 (de)	2003-02-27	Laserdepiliergerät
DE50002834D1 (de)	2003-08-14	Handstempel
DE60001283D1 (de)	2003-03-06	Celluloseetherfilme
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
DE60001894D1 (de)	2003-05-08	Busschienenverbindungsstruktur
DE50015451D1 (de)	2009-01-02	Spülwannensystem
DE59909346D1 (de)	2004-06-03	Zylinderkopfdichtung
DE50009570D1 (de)	2005-03-31	Wechselcorrugator
DE60001649D1 (de)	2003-04-17	Ziprasidonsuspension
DE50008613D1 (de)	2004-12-16	Sicherungsring
DE50016100D1 (de)	2011-06-09	Gabtriebs
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
DE50012482D1 (de)	2006-05-18	Tibiamarknagel
DE60001471D1 (de)	2003-04-03	4-Hydroxyisothiazolverbindungen
DE50003660D1 (de)	2003-10-16	Diacylhydrazinderivate
DE60000940D1 (de)	2003-01-16	Wälzlagerstahl
DE50003259D1 (de)	2003-09-18	Textilie
DE59906520D1 (de)	2003-09-11	Exzenterzahnradgetriebe
DE50008429D1 (de)	2005-01-20	Kraftstofffraktioniereinrichtung
DE50006759D1 (de)	2004-07-15	Piperidinalkohole
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide

Legal Events

Date	Code	Title	Description
2006-07-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application